UnicoCell Biomed Co., Ltd. (6794.TW)

TWD 70.8

(0.28%)

Long Term Debt Summary of UnicoCell Biomed Co., Ltd.

  • UnicoCell Biomed Co., Ltd.'s latest annual long term debt in 2023 was 68.23 Million TWD , up 12.49% from previous year.
  • UnicoCell Biomed Co., Ltd.'s latest quarterly long term debt in 2024 Q2 was 65.14 Million TWD , down 0.0% from previous quarter.
  • UnicoCell Biomed Co., Ltd. reported annual long term debt of 60.65 Million TWD in 2022, up 380.39% from previous year.
  • UnicoCell Biomed Co., Ltd. reported annual long term debt of 12.62 Million TWD in 2021, down -47.12% from previous year.
  • UnicoCell Biomed Co., Ltd. reported quarterly long term debt of 66.69 Million TWD for 2024 Q1, down 0.0% from previous quarter.
  • UnicoCell Biomed Co., Ltd. reported quarterly long term debt of 71.29 Million TWD for 2023 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of UnicoCell Biomed Co., Ltd. (2023 - 2019)

Historical Annual Long Term Debt of UnicoCell Biomed Co., Ltd. (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 68.23 Million TWD 12.49%
2022 60.65 Million TWD 380.39%
2021 12.62 Million TWD -47.12%
2020 23.88 Million TWD 0.0%
2019 - TWD 0.0%

Peer Long Term Debt Comparison of UnicoCell Biomed Co., Ltd.

Name Long Term Debt Long Term Debt Difference
Apex Biotechnology Corp. 116.19 Million TWD 41.275%
Sinphar Pharmaceutical Co.,Ltd. 1.49 Billion TWD 95.433%
Panion & Bf Biotech Inc. 125.41 Million TWD 45.593%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 700 Million TWD 90.252%
GenMont Biotech Incorporation 20.11 Million TWD -239.28%
Abnova (Taiwan) Corporation 2.6 Million TWD -2523.453%
Adimmune Corporation 1.91 Billion TWD 96.442%
Tanvex BioPharma, Inc. 1.56 Billion TWD 95.649%
Polaris Group 352.96 Million TWD 80.668%
Energenesis Biomedical CO.,LTD. - TWD -Infinity%
PELL Bio-Med Technology Co. Ltd. 147.46 Million TWD 53.728%